Trial Profile
A Phase 1, Single-center, Randomized, Open-label Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 (Deuterated [d6] Dextromethorphan Hydrobromide/Quinidine Sulfate) in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jun 2014
Price :
$35
*
At a glance
- Drugs Deudextromethorphan (Primary) ; Dextromethorphan/quinidine
- Indications Major depressive disorder; Neurological disorders; Neuropathic pain; Psychiatric disorders
- Focus Pharmacokinetics
- 30 Jun 2014 New trial record